Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

China Pharma Holdings (CPHI)

China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,780
  • Shares Outstanding, K 5,022
  • Annual Sales, $ 4,530 K
  • Annual Income, $ -4,740 K
  • EBIT $ -3 M
  • EBITDA $ -1 M
  • 60-Month Beta 1.03
  • Price/Sales 1.06
  • Price/Cash Flow N/A
  • Price/Book 0.78

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1800 +30.51%
on 12/26/25
1.8800 -18.09%
on 12/12/25
-0.2000 (-11.49%)
since 12/08/25
3-Month
1.1800 +30.51%
on 12/26/25
2.0000 -23.00%
on 10/09/25
-0.4486 (-22.56%)
since 10/08/25
52-Week
1.1800 +30.51%
on 12/26/25
3.1800 -51.57%
on 03/19/25
-0.5710 (-27.05%)
since 01/08/25

Most Recent Stories

More News
China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

/PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced...

CPHI : 1.5400 (+14.07%)
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

/PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Company") (NYSE American: CPHI) reported that it expects to implement a 1-for-10 reverse...

CPHI : 1.5400 (+14.07%)
China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask

/PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a...

CPHI : 1.5400 (+14.07%)
China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project

/PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a...

CPHI : 1.5400 (+14.07%)
China Pharma Announces Receipt of Noncompliance Notice from NYSE American

/PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced...

CPHI : 1.5400 (+14.07%)
China Pharma Announced the Submission of a Plan of Compliance to NYSE American

/PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced...

CPHI : 1.5400 (+14.07%)
China Pharma Announces Receipt of Noncompliance Notice from NYSE American

/PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced...

CPHI : 1.5400 (+14.07%)

Business Summary

CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson),...

See More

Key Turning Points

3rd Resistance Point 1.4867
2nd Resistance Point 1.4433
1st Resistance Point 1.3967
Last Price 1.5400
1st Support Level 1.3067
2nd Support Level 1.2633
3rd Support Level 1.2167

See More

52-Week High 3.1800
Fibonacci 61.8% 2.4160
Fibonacci 50% 2.1800
Fibonacci 38.2% 1.9440
Last Price 1.5400
52-Week Low 1.1800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar